Targeted α-therapy using 227Th-APOMAB and cross-fire antitumour effects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted α-therapy using 227Th-APOMAB and cross-fire antitumour effects

Published:2014-12 Issue:12 Volume:35 Page:1284-1290
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Staudacher Alexander H.,Bezak Eva,Borysenko Artem,Brown Michael P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference36 articles.

1. Radioimmunotherapy of lymphoma: a treatment approach ahead of its time or past its sell-by date J Clin O;Illidge;ncol,2010

2. . SNM MIRD Committee. MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.;Sgouros;J Nucl Med,2010

3. . Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.;Pagel;Blood,2011

4. . Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.;Park;Blood,2010

5. . Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha-emitting radionuclide, bismuth 213.;Zhang;Blood,2002

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Theranostics: Pharmaceutical View;Pharmaceutical Science;2024-08-21

2. Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals;Inorganic Chemistry;2023-08-17

3. Fc gamma receptor is not required for in vivo processing of radio- and drug-conjugates of the dead tumor cell-targeting monoclonal antibody, APOMAB®;Biomedicine & Pharmacotherapy;2022-07

4. Production of pilot batches 223Ra and 227Th of medical purpose;Applied Radiation and Isotopes;2022-06

5. Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice;Journal of Nuclear Medicine;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3